CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

Interim results from the healthy volunteer dose-escalation study indicate that XmAb942 is well tolerated at single and multiple doses. Pharmacokinetic analysis of the single dose cohorts estimates ...

Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics, Inc. ...

The U.S. Food And Drug Administration approved Jelmyto ... On Friday, UroGen Pharma shared safety data from the Phase 1 dose-escalation study for UGN-301 (zalifrelimab) intravesical solution ...

Last Tuesday, a federal grand jury in Florence, SC, indicted Puquan Huang, 49, of Buford, and Nasir Ullah, 28, and Naim Ullah, 32, both of Sumter, SC, with conspiring to launder millions of ...

This initial dose-escalation study demonstrated a favorable safety profile ... candidates are built on the Company's deep expertise in myeloid biology and cancer drug development. The Company's ...

A common diabetes drug can reduce the pain of people with ... and safely using a telehealth approach, as we did in our study, meaning that it could be provided across the community, including in ...

This initial dose-escalation ... No drug-related serious adverse events (SAEs) were reported One NSCLC patient from the 10 mg/kg cohort had an unconfirmed partial response and remains on study ...

This initial dose-escalation study demonstrated a favorable safety ... Company’s deep expertise in myeloid biology and cancer drug development. The Company’s pipeline includes BDC-3042 ...

With the clearance of an investigational new drug application from the FDA ... Further, Verastem announced that an abstract on the phase 1/2 dose-escalation study of VS-7375 has been accepted into a ...

Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum tolerated dose in up to 50 patients. The FDA granted clearance to the ...